Emergent BioSolutions wins $52.7m smallpox vaccine contract
AI Summary
Emergent BioSolutions won a $52.7 million contract to supply smallpox vaccines, highlighting continued investment in biodefense and public health preparedness.
Emergent BioSolutions won a $52.7 million contract to supply smallpox vaccines, highlighting continued investment in biodefense and public health preparedness.
Bloomberg —
NHK World —
Investing.com —
Investing.com —
The Verge —
Bloomberg —